Pathophysiology of amyotrophic lateral sclerosis
DOI:
https://doi.org/10.56294/shp2026385Keywords:
neurodegenerative diseases, amyotrophic lateral sclerosis, pathophysiologyAbstract
Introduction: Neurodegenerative diseases are hereditary or acquired pathologies that cause progressive dysfunction of the central nervous system. Amyotrophic lateral sclerosis is the most important of the degenerative diseases that can affect motor neurons. The disease is inexorably progressive and leads to death by respiratory paralysis.
Objective: To characterize the evolution and general features of amyotrophic lateral sclerosis.
Materials and methods: A search was conducted in Medline, Pubmed, and Google Scholar, limited to Spanish and English, and documents published mainly in the last five years were selected. However, due to their interest, several papers prior to the established time limit were included. Sixteen papers were included in the review, representing a 62.5% update.
Development: In most patients, risk factors for this disease cannot be identified. Symptoms generally do not appear until after the age of 50. In diagnosing this disease, the neurologist must perform a clinical examination and a series of tests to rule out other diseases that mimic ALS. Although there is no cure, the symptoms can be treated to seek the best possible quality of life.
Conclusions: Amyotrophic lateral sclerosis affects adults of any race or ethnicity. When the muscles of the diaphragm and chest wall fail, breathing becomes impossible without the aid of artificial ventilation. Treatment should be multidisciplinary, offering all patients the opportunity to receive riluzole.
References
1- Escobar M., Pimienta H. Sistema nervioso: Neuroanatomía funcional y clínica. UNIVALLE [INTERNET]. 2019 [1/1/25]. Disponible en: https://books.google.es/books?hl=es&lr=&id=pF_yDwAAQBAJ&oi=fnd&pg=PA9&dq=info:15a_tD_iVyQJ:scholar.google.com/&ots=w-nhsnXzm6&sig=iQlcnovrJFsuf2Wi0G-m4BC1vUM#v=onepage&q&f=false
2- Arosemena R. Enfermedades neurodegenerativas: tipos y diagnóstico. PSYCIENCIA [INTERNET]. 2019 [1/1/25]. Disponible en: https://www.psyciencia.com/enfermedades-neurodegenerativas-tipos-y-diagnostico/
3- Alianza Mundial de lucha contra la ELA. Qué es la ELA? Web de la Asociación Aragonesa de Esclerosis Lateral Amiotrófica [INTERNET]. [1/1/25]. Disponible en: https://www.araela.org/que-es-la-ela/
4- La Esclerosis Lateral Amiotrófica (ELA). Fundela [INTERNET].2018 [1/1/25]. Disponible en: https://www.fundela.es/ela/informacion-general/
5- Serra Ruiz M, Serra Valdés MA. Sobrevida en pacientes con Esclerosis Lateral Amiotrófica. Scielo [INTERNET].2019 [1/1/25] 18(4). Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/2867/2388#:~:text=Su%20incidencia%20aumenta%20a%20partir,seis%20por%20100%20000%20habitantes.
6- CARACTERIZACION EPIDEMIOLOGICA DE LA ESCLEROSIS LATERAL AMIOTROFICA (ELA). Fundela [INTERNET].2018 [1/1/25]. Disponible en: https://www.fundela.es/ela/epidemiologia/
7- Zapata Zapata C; Franco Dáger E; Solano Atehortúa J; Ahunca Velásquez L. Esclerosis lateral amiotrófica: actualización. Scielo [INTERNET].2015 [1/1/25] 29(2). Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-07932016000200008
8- Martínez H, Parada-Garza JD, Meza ME, González-Garza MT, Moreno-Cuevas JE. Esclerosis lateral amiotrófica. Contribución de la Neurología Mexicana de 1998 a 2014. Rev Mex Neuroci [INTERNET].2014 [1/1/25] 15(6). Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.medigraphic.com/pdfs/revmexneu/rmn-2014/rmn146i.pdf&ved=2ahUKEwik7LHOsJb1AhXYSjABHaHTA80QFnoECBUQAQ&usg=AOvVaw0xY4MecXK7fUNRGZaNT89q
9- Navarro Rando M. FACTORES DE RIESGO DE LA ESCLEROSIS LATERAL AMIOTRÓFICA. UNIVERSIDAD DE CASTILLA LA MANCHA [INTERNET]. 2021 [1/1/25]. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.enfermeradigital.com/common/img/tfgs/trabajos/Trabajo%2520fin%2520de%2520grado.pdf&ved=2ahUKEwituKPvtZb1AhX-RDABHaxfBBMQFnoECDMQAQ&usg=AOvVaw3F3p3nD6IcVeERxcfAniAz
10- Fundación Francisco Luzón. La ELA una realidad ignorada [INTERNET]. 2017 [1/1/25]. Disponible en: http://riberdis.cedd.net/handle/11181/6121
11- Esclerosis lateral amiotrófica (ELA). MedlinePlus [INTERNET]. 2021 [1/1/22]. Disponible en: https://medlineplus.gov/spanish/ency/article/000688.htm
12- Carrasco Márquez D. Fisiopatología de la Esclerosis Lateral Amiotrófica. Universidad de Sevilla [INTERNET]. 2016 [1/1/25]. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://idus.us.es/handle/11441/65104&ved=2ahUKEwj83-vQx5b1AhW0RTABHUrqA_gQFnoECA8QAQ&usg=AOvVaw18sEjefS7kMaC93aMu5LT3
13- Ruiz Martínez A. FISIOPATOLOGÍA DE LA ESCLEROSIS LATERAL AMIOTRÓFICA. Universidad de Zaragoza [INTERNET]. 2016 [1/1/25]. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://zaguan.unizar.es/record/57521/files/TAZ-TFG-2016-1323.pdf&ved=2ahUKEwi6laTNxpb1AhVYTDABHR1MDt0QFnoECCYQAQ&usg=AOvVaw180Y0zdh-rAl3HXPYMqSqn
14- Larrodé P. La prevalencia de la Esclerosis Lateral Amiotrófica (ELA). Agencia Noticia 20minutos Zaragoza [INTERNET]. 2011 [1/1/25]. Disponible en: https://www.google.com/amp/s/amp.20minutos.es/noticia/1088545/0/esclerosis/lateral/amiotrofica/
15- Knibb JA. Una herramienta clínica para predecir supervivencia en la ELA. J Neurol Neurosurg Psychiatry [INTERNET] 2016 [1/1/25]. Disponible en: doi:10.1136/jnnp-2015-312908
16- Sáez C. ¿Se puede frenar o revertir la progresión de la ELA? La vanguardia [INTERNET] 2021 [1/1/25]. Disponible en: https://www.google.com/amp/s/www.lavanguardia.com/ciencia/20211018/7788662/frenar-revertir-progresion-ela.amp.html.
Published
Issue
Section
License
Copyright (c) 2026 Ileana Beatriz Quiroga López , Dionis Ruiz Reyes , Diana García Rodríguez , Madyaret Águila Carbelo , Adriel Herrero Díaz (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
